Merck & Co. Number of Vested and Expected to Vest Options increased by 9.2% to $272.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 9.2%, from $249.00M to $272.00M. Over 4 years (FY 2021 to FY 2025), Number of Vested and Expected to Vest Options shows an upward trend with a 6.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
Higher numbers indicate greater potential future dilution, while lower numbers suggest a more conservative equity compensation strategy.
The total count of share-based payment options that have either completed their vesting period or are projected to vest...
Commonly disclosed in equity incentive plan footnotes; varies based on company size and compensation philosophy.
options_vested_and_expected_to_vest| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $212.00M | $539.00M | $438.00M | $249.00M | $272.00M |
| QoQ Change | — | +154.2% | -18.7% | -43.2% | +9.2% |
| YoY Change | — | +154.2% | -18.7% | -43.2% | +9.2% |